Targeting neuropathic pain prevention: Modulating the neuroimmunology of peripheral nerve injury
Targeting neuropathic pain prevention: Modulating the neuroimmunology of peripheral nerve injury
批准号:
10062833
负责人:
LINDA WATKINS
金额:
$34.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-12-01 至 2023-11-30
关键词:
AcuteAdoptive TransferAdultAmericanAnti-Inflammatory AgentsAntioxidantsBehavioralBloodBlood-Nerve BarrierCalpainCellsCenters for Disease Control and Prevention (U.S.)Clinical TreatmentDevelopmentDiseaseDoseEpidemicEventExerciseFemaleGoalsHerbal MedicineHerbalismHumanImmuneImmune responseImmunologicsInjuryInterleukin-10InterventionLeadLeisuresMMP9 geneMediator of activation proteinModelingModerate ExerciseMotionNerveNitric OxideOperative Surgical ProceduresOxidative StressPainPain managementPatientsPeripheral nerve injuryPharmaceutical PreparationsPharmacologyPreventionRattusRecommendationRegimenReportingResearchResolutionRiskRunningSideSiteSymptomsTherapeuticTimeTraumabasecell typechronic constriction injurychronic painclinically relevantcostcytokineendogenous opioidsevidence baseexercise regimeninhibitor/antagonistinterdisciplinary approachmalemonocytenerve injuryneuroimmunologyneutrophilnovelnovel therapeuticspain reliefpainful neuropathypalliativepillpreventsciatic nervesedentaryside effectstatisticstreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Neuropathic pain occurs in epidemic proportions worldwide and none of the currently available therapeutics
provides adequate pain relief and all have significant side effects. None are “disease modifying” as all are
simply palliative in targeting symptoms, not cause. There must be a better approach to pain control.
What we have discovered could potentially revolutionize the clinical treatment of trauma and surgical pa-
tients, all of whom are at marked risk (~50-70%) for developing neuropathic pain. Our discovery is that 6 wk of
moderate voluntary exercise that ceases at the time of nerve trauma appears to permanently suppress the lat-
er development of neuropathic pain. Such an effect has never been previously reported.
The core thesis of this proposal is that novel, superior pharmacological and/or herbalism treatment strate-
gies will arise from understanding how non-pharmacological voluntary exercise produces dramatic prevention
of chronic pain. The critical first step is to understand how VWR prevents chronic pain. This enlightens target-
ed, evidence-based steps toward achieving the same dramatic prevention of pain via pharmacological and/or
herbal medicine approaches. The mechanisms explored in the present proposal are unique from those of any
currently available pain therapeutic. If we can understand and harness prevention of neuropathic pain, this
should lead to early drug interventions of broad practical importance.
How 6 wk voluntary wheel running (VWR) could profoundly influence the cascade of neuroimmunological
and neuropathological events set into motion by later nerve injury has never been explored. This is critical to
understand at a mechanistic level, as prior VWR appears to be the first “disease modifying” approach to con-
trolling whether chronic pain develops. Understanding how this occurs will enable development of novel drug
regimens to pharmacologically duplicate these effects without the necessity of exercise regimens that few peo-
ple will follow.
We predict that understanding how prior voluntary exercise (VWR) exerts such powerful, and seemingly
permanent suppression of neuropathic pain is a tractable research goal, addressable by the multi-disciplinary
approach proposed. This would first seek to understand the behavioral, immunological, neuroimmunological,
and functional effects of: (a) VWR, (b) nerve injury (classic sciatic chronic constriction injury [CCI] model in
male and female rats), and (c) their interaction on the aftermath of nerve injury. Based on these findings,
mechanistic studies are proposed so to begin to explore how prior VWR could exert such a positive, pain-
preventative effect on later nerve injury. Toward this goal, studies that seek to inhibit and to recapitulate the
effects of VWR are both proposed. The long term aim is to capitalize on the understanding of how prior VWR
creates such long-lasting suppression of neuropathic pain so to identify clinically relevant approaches to neu-
ropathic pain prevention, thereby providing a far superior approach to pain control than currently available.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1002/jnr.24645
发表时间:
2022-01
期刊:
Journal of neuroscience research
影响因子:
4.2
作者:
[Green-Fulgham SM, Ball JB, Maier SF, Rice KC, Watkins LR, Grace PM]
通讯作者:
Grace PM
DOI:
10.1097/j.pain.0000000000002589
发表时间:
2022-10-01
期刊:
Pain
影响因子:
7.4
作者:
[]
通讯作者:
DOI:
10.1080/08830185.2021.1921764
发表时间:
2022
期刊:
International reviews of immunology
影响因子:
5
作者:
[Harris KM, Clements MA, Kwilasz AJ, Watkins LR]
通讯作者:
Watkins LR
Enduring enhancement of neuropathic pain by early post-trauma morphine
-
批准号:9906887
-
项目类别:
-
资助金额:$53.04万
-
财政年份:2018
-
负责人:LINDA WATKINS
-
依托单位:
Enduring enhancement of neuropathic pain by early post-trauma morphine
-
批准号:10393512
-
项目类别:
-
资助金额:$53.04万
-
财政年份:2018
-
负责人:LINDA WATKINS
-
依托单位:
Targeting toll like receptor 4 (TLR4) and TLR2 to resolve EAE-associated paralysis, pain and cognitive deficits: efficacy of a clinically-relevant blood brain barrier permeable TLR4/TLR2 antagonist
-
批准号:9153350
-
项目类别:
-
资助金额:$33.68万
-
财政年份:2016
-
负责人:LINDA WATKINS
-
依托单位:
Spinal adenosine modulator: enduring anti-inflammatory action in neuropathic pain
-
批准号:7805660
-
项目类别:
-
资助金额:$37.47万
-
财政年份:2009
-
负责人:LINDA WATKINS
-
依托单位:
Spinal adenosine modulator: enduring anti-inflammatory action in neuropathic pain
-
批准号:7937819
-
项目类别:
-
资助金额:$37.46万
-
财政年份:2009
-
负责人:LINDA WATKINS
-
依托单位:
Models and mechanisms for the transition of acute-to-chronic orofacial pain
-
批准号:7936108
-
项目类别:
-
资助金额:$33.79万
-
财政年份:2009
-
负责人:LINDA WATKINS
-
依托单位:
Models and mechanisms for the transition of acute-to-chronic orofacial pain
-
批准号:7805658
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2009
-
负责人:LINDA WATKINS
-
依托单位:
Optoid Analgesics: Modulation of Trigeminal & Spinal Glial Activation
-
批准号:7840785
-
项目类别:
-
资助金额:$2.12万
-
财政年份:2009
-
负责人:LINDA WATKINS
-
依托单位:
Immune and Gilia Regulation of Pain & Analgesic Actions
-
批准号:8284453
-
项目类别:
-
资助金额:$12.33万
-
财政年份:2008
-
负责人:LINDA WATKINS
-
依托单位:
Exploring the Potential of Glia for Regulating Clinically Relevant Opiod Actions
-
批准号:8267435
-
项目类别:
-
资助金额:$1.19万
-
财政年份:2008
-
负责人:LINDA WATKINS
-
依托单位:
Exploring the Potential of Glia for Regulating Clinically Relevant Opiod Actions
-
批准号:7765583
-
项目类别:
-
资助金额:$37.1万
-
财政年份:2008
-
负责人:LINDA WATKINS
-
依托单位:
Exploring the Potential of Glia for Regulating Clinically Relevant Opiod Actions
-
批准号:7768258
-
项目类别:
-
资助金额:$7.17万
-
财政年份:2008
-
负责人:LINDA WATKINS
-
依托单位:
Exploring the Potential of Glia for Regulating Clinically Relevant Opiod Actions
-
批准号:8019033
-
项目类别:
-
资助金额:$35.98万
-
财政年份:2008
-
负责人:LINDA WATKINS
-
依托单位:
Optoid Analgesics: Modulation of Trigeminal & Spinal Glial Activation
-
批准号:7677801
-
项目类别:
-
资助金额:$7.14万
-
财政年份:2008
-
负责人:LINDA WATKINS
-
依托单位:
Immune and Gilia Regulation of Pain & Analgesic Actions
-
批准号:7643967
-
项目类别:
-
资助金额:$12.33万
-
财政年份:2008
-
负责人:LINDA WATKINS
-
依托单位:
Immune and Gilia Regulation of Pain & Analgesic Actions
-
批准号:8118548
-
项目类别:
-
资助金额:$12.33万
-
财政年份:2008
-
负责人:LINDA WATKINS
-
依托单位:
Exploring the Potential of Glia for Regulating Clinically Relevant Opiod Actions
-
批准号:8215920
-
项目类别:
-
资助金额:$35.96万
-
财政年份:2008
-
负责人:LINDA WATKINS
-
依托单位:
Exploring the Potential of Glia for Regulating Clinically Relevant Opiod Actions
-
批准号:8471472
-
项目类别:
-
资助金额:$1.54万
-
财政年份:2008
-
负责人:LINDA WATKINS
-
依托单位:
Immune and Gilia Regulation of Pain & Analgesic Actions
-
批准号:7498731
-
项目类别:
-
资助金额:$12.33万
-
财政年份:2008
-
负责人:LINDA WATKINS
-
依托单位:
Exploring the Potential of Glia for Regulating Clinically Relevant Opiod Actions
-
批准号:7365436
-
项目类别:
-
资助金额:$34.14万
-
财政年份:2008
-
负责人:LINDA WATKINS
-
依托单位:
海外基金